The pharmacological treatment of migraine in children and adolescents: An overview

Expert Review of Neurotherapeutics

Volumn 12, Issue 9, 2012, Pages 1133-1142

  Toldo, Irene ^a   De Carlo, Debora ^a   Bolzonella, Barbara ^a   Sartori, Stefano ^a   Battistella, Pier Antonio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

children and adolescents; migraine; pharmacological treatment

Indexed keywords

ALMOTRIPTAN; AMITRIPTYLINE; ANTIMIGRAINE AGENT; CAFFEINE; CLONIDINE; CYPROHEPTADINE; DIHYDROERGOTAMINE; DOMPERIDONE; ELETRIPTAN; ETIRACETAM; FLUNARIZINE; IBUPROFEN; INDOMETACIN; KETOROLAC; METOCLOPRAMIDE; NARATRIPTAN; NIMESULIDE; NIMODIPINE; PARACETAMOL; PIZOTIFEN; PROCHLORPERAZINE; PROMETHAZINE; PROPRANOLOL; RIZATRIPTAN; SUMATRIPTAN; TOPIRAMATE; TRAZODONE; UNINDEXED DRUG; VALPROATE SEMISODIUM; ZOLMITRIPTAN;

ACCURACY; ADOLESCENT; ASTHENIA; BLOOD BRAIN BARRIER; CHILD; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; EXTRAPYRAMIDAL SYMPTOM; HEMOLYTIC ANEMIA; HUMAN; HYPOTENSION; LIVER FAILURE; MIGRAINE; MULTICENTER STUDY (TOPIC); NAUSEA AND VOMITING; PANCYTOPENIA; PATIENT SELECTION; PHOTOPHOBIA; PRIMARY HEALTH CARE; PROTEIN BINDING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; REVIEW; SEDATION; SIDE EFFECT; STOMACH PAIN; TIME TO MAXIMUM PLASMA CONCENTRATION; VERTIGO;

ADOLESCENT; ANALGESICS, NON-NARCOTIC; CALCIUM CHANNEL BLOCKERS; CHILD; EVIDENCE-BASED MEDICINE; HUMANS; MIGRAINE DISORDERS; RECURRENCE; SEROTONIN RECEPTOR AGONISTS;

EID: 84867309063     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.12.104     Document Type: Review

References (91)

1. Lewis DW, Ashwal S, Dahl G et al. Quality Standards Subcommittee of the American Academy of Neurology; Practice Committee of the Child Neurology Society. Practice parameter: evaluation of children and adolescents with recurrent headaches: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 59(4), 490-498 (2002).
2. Linee Guida per la diagnosi e la terapia della cefalea giovanile. Il Giornale SISC anno V (Suppl. 1), 1-37 (2003).
3. Géraud G, Lantéri-Minet M, Lucas C, Valade D; French Society for the Study of Migraine Headache (SFEMC). French guidelines for the diagnosis and management of migraine in adults and children. Clin. Ther. 26(8), 1305-1318 (2004).
4. Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S; American Academy of Neurology Quality Standards Subcommittee; Practice Committee of the Child Neurology Society. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology 63(12), 2215-2224 (2004).
5. Cuvellier JC, Donnet A, Guégan-Massardier E, Nachit-Ouinekh F, Parain D, Vallée L; Céleste Study Group. Treatment of primary headache in children: a multicenter hospital-based study in France. J. Headache Pain 10(6), 447-453 (2009).
6. Hershey AD, Kabbouche MA, Powers SW. Treatment of pediatric and adolescent migraine. Pediatr. Ann. 39(7), 416-423 (2010).
7. Hershey AD. Current approaches to the diagnosis and management of paediatric migraine. Lancet Neurol. 9(2), 190-204 (2010).
8. Termine C, Ozge A, Antonaci F, Natriashvili S, Guidetti V, Wöber-Bingöl C. Overview of diagnosis and management of paediatric headache. Part II: therapeutic management. J. Headache Pain 12(1), 25-34 (2011).
9. Fernandes R, Ferreira JJ, Sampaio C. The placebo response in studies of acute migraine. J. Pediatr. 152(4), 527-533, 533.e1 (2008).
10. Damen L, Bruijn JK, Verhagen AP, Berger MY, Passchier J, Koes BW. Symptomatic treatment of migraine in children: a systematic review of medication trials. Pediatrics 116(2), e295-e302 (2005).
11. Hershey AD, Winner PK. Pediatric migraine: recognition and treatment. J. Am. Osteopath. Assoc. 105(Suppl. 2), 2-8 (2005).
12. Silver S, Gano D, Gerretsen P. Acute treatment of paediatric migraine: a meta-analysis of efficacy. J. Paediatr. Child Health 44(1-2), 3-9 (2008).
13. Victor S, Ryan SW. Drugs for preventing migraine headache in children (Cochrane review). In: The Cochrane Library. John Wiley & Sons Ltd, Chichester, UK (2003).
14. O'Brien HL, Kabbouche MA, Hershey AD. Treatment of acute migraine in the pediatric population. Curr. Treat. Options Neurol. 12(3), 178-185 (2010).
15. Hämäläinen ML. Migraine in children and adolescents: a guide to drug treatment. CNS Drugs 20(10), 813-820 (2006).
16. Winner P, Lewis DW. Young Adult and Pediatric Headache Management. BC Decker Inc Hamilton, ON, Canada (2005).
17. Lewis DW, Winner P. The pharmacological treatment options for pediatric migraine: an evidence-based appraisal. NeuroRx 3(2), 181-191 (2006).
18. Balottin U, Termine C. Recommendations for the management of migraine in paediatric patients. Expert Opin. Pharmacother. 8(6), 731-744 (2007).
19. Lewis DW, Kellstein D, Dahl G et al. Children's ibuprofen suspension for the acute treatment of pediatric migraine. Headache 42(8), 780-786 (2002).
20. Hämäläinen ML, Hoppu K, Valkeila E et al. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology 48, 102-107 (1997).
21. Soriani S, Battistella PA, Naccarella C et al. Nimesulide and acetaminophen for the treatment of juvenile migraine: a study for comparison of efficacy safety and tolerability. Headache Quater: Curr. Treatment Res. 12, 233-236 (2001).
22. Moorjani BI, Rothner AD. Indomethacinresponsive headaches in children and adolescents. Semin. Pediatr. Neurol. 8(1), 40-45 (2001).
23. Hoy SM, Scott LJ. Indomethacin/ prochlorperazine/caffeine: a review of its use in the acute treatment of migraine and in the treatment of episodic tension-type headache. CNS Drugs 25(4), 343-358 (2011).
24. Hering-Hanit R, Gadoth N, Cohen A, Horev Z. Successful withdrawal from analgesic abuse in a group of youngsters with chronic daily headache. J. Child Neurol. 16(6), 448-449 (2001).
25. Pothmann R, Luka-Krausgrill U, Seemann H, Naumann E. [Treatment of headache in children. Recommendations of the pain therapy study group of the DGCS]. Schmerz 15(4), 265-271 (2001).
26. Pothmann R. [Headache in children]. Schmerz 4(1), 7-13 (1990).
27. Richer LP, Laycock K, Miller K et al. Treatment of children with migraine in emergency departments: national practice variation study. Pediatrics 126, e150-e155 (2010).
28. Mastrosimone F, Decaterina G, Iaccarino C et al. The dopaminergic antagonists in childhood headache. In: Headache in Children and Adolescents. Proceedings of the First International Symposium on Headache in Children and Adolescents (19-20 May 1988, Pavia, Italy). Lanzi G, Balottin U, Cernibori A (Eds). Elsevier Science Ltd, NY, USA, 233-236 (1989).
29. Linder SL. Treatment of childhood headache with dihydroergotamine mesylate. Headache 34(10), 578-580 (1994).
30. Kabbouche MA, Vockell AL, LeCates SL, Powers SW, Hershey AD. Tolerability and effectiveness of prochlorperazine for intractable migraine in children. Pediatrics 107(4), E62 (2001).
31. Brousseau DC, Duffy SJ, Anderson AC, Linakis JG. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac. Ann. Emerg. Med. 43(2), 256-262 (2004).
32. Hämäläinen ML, Hoppu K, Santavuori P. Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Neurology 48, 1100-1103 (1997).
33. Callenbach PM, Pels LP, Mulder PG et al. SUM30042 Trial Group. Sumatriptan nasal spray in the acute treatment of migraine in adolescents and children. Eur. J. Paediatr. Neurol. 11(6), 325-330 (2007).
34. Major PW, Grubisa HS, Thie NM. Triptans for treatment of acute pediatric migraine: a systematic literature review. Pediatr. Neurol. 29(5), 425-429 (2003).
35. Eiland LS, Hunt MO. The use of triptans for pediatric migraines. Paediatr. Drugs 12(6), 379-389 (2010).
36. Vollono C, Vigevano F, Tarantino S, Valeriani M. Triptans other than sumatriptan in child and adolescent migraine: literature review. Expert Rev. Neurother. 11(3), 395-401 (2011).
37. Lewis DW. Almotriptan for the acute treatment of adolescent migraine. Expert Opin. Pharmacother. 11(14), 2431-2436 (2010).
38. Derosier FJ, Lewis D, Hershey AD et al. Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine. Pediatrics 129(6), e1411-e1420 (2012).
39. MacDonald JT. Treatment of juvenile migraine with subcutaneous sumatriptan. Headache 34(10), 581-582 (1994).
40. Linder SL. Subcutaneous sumatriptan in the clinical setting: the first 50 consecutive patients with acute migraine in a pediatric neurology office practice. Headache 36(7), 419-422 (1996).
41. Ueberall MA, Wenzel D. Intranasal sumatriptan for the acute treatment of migraine in children. Neurology 52(7), 1507-1510 (1999).
42. Winner P, Rothner AD, Saper J et al. A randomized, double-blind, placebocontrolled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics 106(5), 989-997 (2000).
43. Ahonen K, Hämäläinen ML, Rantala H, Hoppu K. Nasal sumatriptan is effective in treatment of migraine attacks in children: a randomized trial. Neurology 62(6), 883-887 (2004).
44. Winner P, Rothner AD, Wooten JD, Webster C, Ames M. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebocontrolled, acute study. Headache 46(2), 212-222 (2006).
45. Battistella PA. Symptomatic treatment of paediatric migraine: an open-label study with sumatriptan nasal spray. J. Headache Pain 8(Suppl.), S22 (2007).
46. Linder SL, Dowson AJ. Zolmitriptan provides effective migraine relief in adolescents. Int. J. Clin. Pract. 54(7), 466-469 (2000).
47. Rothner AD, Wasiewski W, Winner P, Lewis D, Stankowski J. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents. Headache 46(1), 101-109 (2006).
48. Evers S, Rahmann A, Kraemer C et al. Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen. Neurology 67(3), 497-499 (2006).
49. Lewis DW, Winner P, Hershey AD, Wasiewski WW; Adolescent Migraine Steering Committee. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics 120(2), 390-396 (2007).
50. Winner P, Lewis D, Visser WH, Jiang K, Ahrens S, Evans JK; Rizatriptan Adolescent Study Group. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebocontrolled study. Headache 42(1), 49-55 (2002).
51. Visser WH, Winner P, Strohmaier K et al; Rizatriptan Protocol 059 and 061 Study Groups. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies. Headache 44(9), 891-899 (2004).
52. Ahonen K, Hämäläinen ML, Eerola M, Hoppu K. A randomized trial of rizatriptan in migraine attacks in children. Neurology 67(7), 1135-1140 (2006).
53. Winner P, Linder SL, Lipton RB, Almas M, Parsons B, Pitman V. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebocontrolled trial. Headache 47(4), 511-518 (2007).
54. Baldwin JR, Fleishaker JC, Azie NE, Carel BJ. A comparison of the pharmacokinetics and tolerability of the anti-migraine compound almotriptan in healthy adolescents and adults. Cephalalgia 24(4), 288-292 (2004).
55. Linder SL, Mathew NT, Cady RK, Finlayson G, Ishkanian G, Lewis DW. Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial. Headache 48(9), 1326-1336 (2008).
56. Berenson F, Vasconcellos E, Pakalnis A, Mao L, Biondi DM, Armstrong RB. Long-term, open-label safety study of oral almotriptan 12.5 mg for the acute treatment of migraine in adolescents. Headache 50(5), 795-807 (2010).
57. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia 24, 1-160 (2004).
58. Battistella PA. Nuovi orientamenti nelle terapie di profilassi. In: La Testa Che Duole: Le Cefalee Nel Bambino e Dell'adolescente. Guidetti V, Lanzi G, Levi G (Eds). Carocci, Roma, Italy, 207-218 (2002).
59. Lewis DW. Toward the definition of childhood migraine. Curr. Opin. Pediatr. 16(6), 628-636 (2004).
60. Damen L, Bruijn J, Verhagen AP, Berger MY, Passchier J, Koes BW. Prophylactic treatment of migraine in children. Part 2. A systematic review of pharmacological trials. Cephalalgia 26(5), 497-505 (2006).
61. Eiland LS, Jenkins LS, Durham SH. Pediatric migraine: pharmacologic agents for prophylaxis. Ann. Pharmacother. 41(7), 1181-1190 (2007).
62. Cuvellier JC, Joriot S, Auvin S, Vallée L. [Drug treatment of migraine in children: state of the art]. Arch. Pediatr. 11(5), 449-455 (2004).
63. Kienbacher C, Wöber C, Zesch HE et al. Clinical features, classification and prognosis of migraine and tension-type headache in children and adolescents: a long-term follow-up study. Cephalalgia 26(7), 820-830 (2006).
64. Guidetti V, Galli F. Evolution of headache in childhood and adolescence: an 8-year follow-up. Cephalalgia 18(7), 449-454 (1998).
65. Wasiewski WW. Preventive therapy in pediatric migraine. J. Child Neurol. 16(2), 71-78 (2001).
66. Sorge F, De Simone R, Marano E, Nolano M, Orefice G, Carrieri P. Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. Cephalalgia 8(1), 1-6 (1988).
67. Ludvigsson J. Propranolol used in prophylaxis of migraine in children. Acta Neurol. Scand. 50(1), 109-115 (1974).
68. Sartory G, Müller B, Metsch J, Pothmann R. A comparison of psychological and pharmacological treatment of pediatric migraine. Behav. Res. Ther. 36(12), 1155-1170 (1998).
69. Salmon MA, Walters DD. Pizotifen in the prophylaxis of cyclical vomiting. Lancet 1(8436), 1036-1037 (1985).
70. Gillies D, Sills M, Forsythe I. Pizotifen (Sanomigran) in childhood migraine. A double-blind controlled trial. Eur. Neurol. 25(1), 32-35 (1986).
71. Bille B, Ludvigsson J, Sanner G. Prophylaxis of migraine in children. Headache 17(2), 61-63 (1977).
72. Sorge F, Barone P, Steardo L, Romano MR. Amitriptyline as a prophylactic for migraine in children. Acta Neurol. (Napoli) 4(5), 362-367 (1982).
73. Hershey AD, Powers SW, Bentti AL, Degrauw TJ. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache 40(7), 539-549 (2000).
74. Lavinstein B. A comparative study of cyproheptadine, amitriptyline and propranolol in the treatment of adolescent migraine. Cephalalgia 11, 122-123 (1991).
75. Eidlitz-Markus T, Dlugatch Y, Haimi-Cohen Y, Goldberg-Stern H, Zeharia A. Nonpharmacologic treatment of migraine with low-dose propranolol or amitriptyline. Pediatr. Neurol. 46(6), 345-349 (2012).
76. Battistella PA, Ruffilli R, Cernetti R et al. A placebo-controlled crossover trial using trazodone in pediatric migraine. Headache 33(1), 36-39 (1993).
77. Eiland LS. Anticonvulsant use for prophylaxis of the pediatric migraine. J. Pediatr. Health Care 21(6), 392-395; quiz 396 (2007).
78. Caruso JM, Brown WD, Exil G, Gascon GG. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine. Headache 40(8), 672-676 (2000).
79. Serdaroglu G, Erhan E, Tekgul H et al. Sodium valproate prophylaxis in childhood migraine. Headache 42(8), 819-822 (2002).
80. Apostol G, Cady RK, Laforet GA et al. Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebocontrolled study. Headache 48(7), 1012-1025 (2008).
81. Unalp A, Uran N, Oztürk A. Comparison of the effectiveness of topiramate and sodium valproate in pediatric migraine. J. Child Neurol. 23(12), 1377-1381 (2008).
82. Hershey AD, Powers SW, Vockell AL, LeCates S, Kabbouche M. Effectiveness of topiramate in the prevention of childhood headaches. Headache 42(8), 810-818 (2002).
83. Campistol J, Campos J, Casas C, Herranz JL. Topiramate in the prophylactic treatment of migraine in children. J. Child Neurol. 20(3), 251-253 (2005).
84. Winner P, Pearlman EM, Linder SL et al. Topiramate Pediatric Migraine Study Investigators. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache 45, 1304-1312 (2005).
85. Lakshmi CV, Singhi P, Malhi P, Ray M. Topiramate in the prophylaxis of pediatric migraine: a double-blind placebocontrolled trial. J. Child Neurol. 22(7), 829-835 (2007).
86. Lewis D, Winner P, Saper J et al. Randomized, double-blind, placebocontrolled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics 123(3), 924-934 (2009).
87. Miller GS. Efficacy and safety of levetiracetam in pediatric migraine. Headache 44(3), 238-243 (2004).
88. Pakalnis A, Kring D, Meier L. Levetiracetam prophylaxis in pediatric migraine-an open-label study. Headache 47(3), 427-430 (2007).
89. Belman AL, Milazo M, Savatic M et al. Gabapentin for migraine prophylaxis in children. Ann. Neurol. 50(Suppl. 1), 109 (2001).
90. Hershey AD, Winner P, Kabbouche MA, Powers SW. Headaches. Curr. Opin. Pediatr. 19(6), 663-669 (2007).
91. Richer LP, Laycock K, Millar K et al. Treatment of children with migraine in emergency departments: national practice variation study. Pediatrics 126(1), e150-155 (2001).